Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
It produces more modest results than semaglutide or tirzepatide, typically around 8 percent body weight loss, but it was the first GLP-1 to receive FDA approval specifically for weight management and remains a viable option for patients who prefer a shorter-acting medication or who experience intolerable side effects on the more potent formulations
Clinical trial data shows meaningful weight loss in the first 12 weeks of GLP-1 treatment, though results vary significantly based on starting weight, the specific medication, dose, dietary choices, and activity level
Who should not take a GLP-1, full stop The boxed warning converts into a hard rule for a specific group
& De, A
Not in your basic metabolic panel
My shoulders were my strong area and the left one is now atrophied some
